TNF and Alzheimer disease: TNF-α-mediated inflammation is recognized as a significant mechanism of AD induction, and anti-TNF therapy has been shown to decrease the pathological brain changes in rodent models of AD, as well as to slow down cognitive decline and improve everyday function in patients with AD [62].